| [1]Mariana Rey, Hector Coirini. Synthetic neurosteroids on brain protection[J]. Neural Regeneration Research, 2015, 10(1):17-21.[2]Roberto Cosimo Melcangi, Ayikoe Guy Mensah-Nyagan. Neurosteroids: measurement and pathophysiologic relevance[J]. Neurochemistry International, 2008, 52(4–5):503-505.[3]Cornelius Schüle, Caroline Nothdurfter, Rainer Rupprecht. The role of allopregnanolone in depression and anxiety[J]. Progress in Neurobiology, 2014, 113(3):79-87. [4]Anjana Bali, Amteshwar Singh Jaggi. Multifunctional aspects of allopregnanolone in stress and related disorders[J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2014, 48(42):64-78.[5]Schumacher M, Mattern C, Ghoumari A, et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors[J]. Progress in Neurobiology, 2014, 113(1):6-39.[6]Cornelius Schüle, Eser D, Thomas C Baghai, et al. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?[J]. Neuroscience, 2011, 191:55-77.[7]Caroline Nothdurfter, Thomas C Baghai, Cornelius Schüle, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders[J]. European Archives of Psychiatry and Clinical Neuroscience, 2012, 262 Suppl 2(2):107-112. [8]Rainer Rupprecht, Vassilios Papadopoulos, Gerhard Rammes, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders[J]. Nature Reviews Drug Discovery, 2010, 9(12):971-988.[9]Zheng Ping. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance[J]. Progress in Neurobiology, 2009, 89(2):134-152.[10]Veska Uzunova, Aileen S Wrynn, Anu Kinnunen, et al. Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat[J]. European J Pharmacology, 2004, 486(1):31-34.[11]Kinzo Matsumoto, Giulia Puia, Erbo Dong, et al. GABA(A) receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders[J]. Stress-the International Journal on the Biology of Stress, 2007, 10(1):3-12.[12]Yukihiko Shirayama, Andrew C H Chen, Shin Nakagawa, et al. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression[J]. J Neuroscience the Official Journal of the Society for Neuroscience, 2002, 22(8):3251-3261.[13]Erbo Dong, Kinzo Matsumoto, Veska Uzunova, et al. Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation[J]. Proceedings of the National Academy of Sciences, 2001, 98(5):2849-2854. [14]Laura Mòdol, Sonia Darbra, Marc Pallarès. Neurosteroids infusion into the CA1 hippocampal region on exploration, anxiety-like behaviour and aversive learning[J]. Behavioural Brain Research, 2011, 222(1):223-229. [15]Francesca Brambilla, Carmen Mellado, Alessandra Alciati, et al. Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder[J]. Psychiatry Research, 2005, 135(3):185-190. [16]Singh A, Kumar A. Possible GABAergic modulation in the protective effect of allopregnanolone on sleep deprivation-induced anxiety-like behavior and oxidative damage in mice[J]. Methods & Findings in Experimental & Clinical Pharmacology, 2008, 30(9):681-709.[17]Alicia A Walf, Kanako Sumida, Cheryl A Frye. Inhibiting 5alpha-reductase in the amygdala attenuates antianxiety and antidepressive behavior of naturally receptive and hormone-primed ovariectomized rats[J]. Psychopharmacology, 2006, 186 (3):302-311.[18] Elif Engin, Dallas Treit. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus[J]. Behav Pharmacol, 2007, 18(5-6): 461–470. [19]Frye C A, Paris J J. Progesterone turnover to its 5α-reduced metabolites in the ventral tegmental area of the midbrain is essential for initiating social and affective behavior and progesterone metabolism in female rats [J]. J Endocrinological Investigation, 2011, 34(7): e188-e199.[20]杨红菊, 赵楠, 罗质璞. 神经类固醇对学习记忆与应激性情绪反应的调控作用[J]. 国际药学研究杂志, 2001, 28(3): 140-144.[21]Follesa P, Porcu P, Sogliano C, et al. Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats[J]. Neuropharmacology, 2002, 42(3):325-336.[22]Shirayama Y, Muneoka K, Fukumoto M, et al. Infusions of allopregnanolone into the hippocampus and amygdala, but not into the nucleus accumbens and medial prefrontal cortex, produce antidepressant effects on the learned helplessness rats[J]. Hippocampus, 2011, 21(10):1105-1113.[23]刘畅, 张黎明, 杨卫星, 等. 18ku转位蛋白:焦虑症治疗的潜在新靶点[J]. 国际药学研究杂志, 2016, 43(2):229-233.[24] Jane Evans, Sun Yu-hui, Ailsa Mcgregor, et al. Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress[J]. Neuropharmacology, 2012, 63(8):1315-1326. [25]李云峰, 杨明, 赵毅民,等. 巴戟天寡糖对皮质酮损伤的PC12细胞的保护作用[J]. 中国中药杂志, 2000, 25(9):551-554.[26]Schüle C, Eser D, Baghai T C, et al. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?[J]. Neuroscience, 2011, 191: 55-77.[27]Pierrick Poisbeau, Anne Florence Keller, Maya Aouad, et al. Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone[J]. Frontiers in Cellular Neuroscience, 2014, 8(8):174-174. [28]Bail Anjana, Amteshwar Singh Jaggi. Multifunctional aspects of allopregnanolone in stress and related disorders[J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2014, 48(42): 64-78. |
